Holders — by stockHoldings — by fund
Nextech Invest Ltd.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001595430
$2.23B
disclosed book value
18
positions
69.9%
largest position share
Positions, as of 2026-09-30
top 18 of 18 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 7.6M | $1.56B | 69.9% |
| 2 | PBLSPARABILIS MEDICINES INC | 4.7M | $150.6M | 6.7% |
| 3 | RLAYRELAY THERAPEUTICS INC | 6.8M | $122.3M | 5.5% |
| 4 | ORICORIC PHARMACEUTICALS INC | 7.2M | $96.5M | 4.3% |
| 5 | TYRATYRA BIOSCIENCES INC | 3.4M | $75.4M | 3.4% |
| 6 | ALMSALUMIS INC | 4.6M | $33.6M | 1.5% |
| 7 | ATTOATTOVIA THERAPEUTICS INC | 1.8M | $31.5M | 1.4% |
| 8 | KYMRKYMERA THERAPEUTICS INC | 278,896 | $31.2M | 1.4% |
| 9 | ETRAELECTRA THERAPEUTICS INC | 2.6M | $29.7M | 1.3% |
| 10 | ZYMEZYMEWORKS INC | 1.1M | $29.5M | 1.3% |
| 11 | SLNSILENCE THERAPEUTICS PLC | 1.7M | $18.5M | 0.8% |
| 12 | CTMXCYTOMX THERAPEUTICS INC. | 4.4M | $12.1M | 0.5% |
| 13 | AVTXAVALO THERAPEUTICS INC | 766,000 | $11.7M | 0.5% |
| 14 | GLUEMONTE ROSA THERAPEUTICS INC | 761,153 | $9.1M | 0.4% |
| 15 | BRVEBRAVEHEART BIO INC | 416,700 | $8.4M | 0.4% |
| 16 | CRVSCORVUS PHARMACEUTICALS INC | 450,000 | $5.2M | 0.2% |
| 17 | ENGNENGENE THERAPEUTICS INC | 2.3M | $4.6M | 0.2% |
| 18 | CNTXCONTEXT THERAPEUTICS INC | 7.4M | $2.2M | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.